You have 9 free searches left this month | for more free features.

Ascendis Pharma

Showing 1 - 25 of 222

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Turner Syndrome Trial in United States (Lonapegsomatropin, Somatropin)

Recruiting
  • Turner Syndrome
  • Los Angeles, California
  • +17 more
Jan 23, 2023

Achondroplasia Trial in Worldwide (TransCon CNP, Placebo for TransCon CNP, sWfI Placebo for TransCon CNP)

Active, not recruiting
  • Achondroplasia
  • TransCon CNP
  • +2 more
  • Little Rock, Arkansas
  • +14 more
Dec 20, 2022

Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo)

Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo
  • San Francisco, California
  • +20 more
Aug 5, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (Lonapegsomatropin, Placebo,

Recruiting
  • Growth Hormone Deficiency
  • +2 more
  • Phoenix, Arizona
  • +63 more
Apr 12, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022

Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo for TransCon PTH)

Active, not recruiting
  • Hypoparathyroidism
  • +2 more
  • TransCon PTH
  • Placebo for TransCon PTH
  • Chicago, Illinois
  • +14 more
Mar 2, 2022

Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases Trial in Worldwide (Once weekly

Completed
  • Growth Hormone Deficiency, Pediatric
  • +4 more
  • Once weekly subcutaneous injection of TransCon hGH
  • Once daily subcutaneous injection of Genotropin
  • Birmingham, Alabama
  • +52 more
Dec 6, 2021

Achondroplasia Trial in China (TransCon CNP, Placebo for TransCon CNP)

Recruiting
  • Achondroplasia
  • TransCon CNP
  • Placebo for TransCon CNP
  • Beijing, China
  • +5 more
Feb 9, 2022

Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)

Active, not recruiting
  • Growth Hormone Deficiency, Pediatric
  • +3 more
  • TransCon hGH
  • Birmingham, Alabama
  • +41 more
Oct 13, 2021

Growth Hormone Deficiency Trial in Centennial (No intervention)

Recruiting
  • Growth Hormone Deficiency
  • No intervention
  • Centennial, Colorado
    Ascendis Pharma Investigational Site
Apr 18, 2023

Achondroplasia Trial in Parkville (TransCon CNP)

Recruiting
  • Achondroplasia
  • TransCon CNP
  • Parkville, Victoria, Australia
    Ascendis Pharma Investigational Site
Jun 30, 2023

Adult Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency Trial in Las Vegas (Lonapegsomatropin)

Recruiting
  • Adult Growth Hormone Deficiency
  • +2 more
  • Las Vegas, Nevada
    Ascendis Pharma Investigational Site
Dec 28, 2021

Achondroplasia Trial (Navepegritide, Placebo for Navepegritide)

Not yet recruiting
  • Achondroplasia
  • (no location specified)
Oct 6, 2023

Hypoparathyroidism Trial (Palopegteriparatide (TransCon PTH))

Available
  • Hypoparathyroidism
  • Palopegteriparatide (TransCon PTH)
  • (no location specified)
Jan 10, 2023

A Prospective, Non-interventional, Long-term, Post-Authorisation

Not yet recruiting
  • Growth Hormone Deficiency
  • No intervention
  • (no location specified)
Mar 8, 2023

Growth Hormone Deficiency, Endocrine System Diseases, Hormones Trial in Wuhan (TransCon hGH, daily hGH)

Unknown status
  • Growth Hormone Deficiency
  • +4 more
  • TransCon hGH
  • daily hGH
  • Wuhan, Hubei, China
    Department of Pediatrics, Tongji Hospital, Tongji Medical Colleg
Mar 27, 2020

Achondroplasia Trial (TransCon CNP, Placebo for TransCon CNP)

Not yet recruiting
  • Achondroplasia
  • TransCon CNP
  • Placebo for TransCon CNP
  • (no location specified)
Jan 11, 2023

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)

Completed
  • Growth Hormone Deficiency, Pediatric
  • +3 more
  • TransCon hGH
  • Birmingham, Alabama
  • +23 more
Dec 7, 2021

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

Recruiting
  • Bioequivalence
  • RID-TDS 13.3 mg/24 h
  • Exelon® 13.3 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023

Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg

Active, not recruiting
  • Hypertension
  • Coronary Artery Disease
  • Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
  • Norvasc 5 mg tablets of Pfizer Labs
  • Vadodara, Gujarat, India
    Accutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023

Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Olivos, Buenos Aires, Argentina
  • +5 more
May 10, 2023

Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))

Completed
  • Healthy
  • Gleptomet 50/1000(Metformin HCl & Sitagliptin)
  • Janumet 50/1000(Metformin HCl & Sitagliptin)
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 22, 2023